Treatment Ratings slipped virtually 8 for each cent on Thursday, immediately after experiences recommended that S B Mainak, chairman, Treatment Ratings has tendered his resignation.
Current market regulator Securities and Trade Board of India (Sebi) is stated to have nudged the ranking agency to remove Mainak immediately after adverse results in opposition to him in a forensic report.
“Pursuant to Regulation thirty of the SEBI (Listing Obligations and Disclosure Specifications) Restrictions 2015, you should be educated that due to individual explanations Shri. S B Mainak, Chairman & Independent Director of the Firm has tendered his resignation with effect from February eleven, 2020,” the firm stated in a regulatory filing to the BSE. Go through IT Right here
This is the 2nd setback for the ranking agency in as quite a few months. Previously in December 2019, the company’s taking care of director and main govt officer (MD & CEO) Rajesh Mokashi experienced stepped down pursuing whistle blower criticism alleging administration interference in rankings of certain corporations, together with IL&FS. A lot more Info Right here
At ten:10am, the stock was buying and selling 7.5 for each cent lower at Rs 538 ranges on the BSE. In comparison, the S&P BSE Sensex was buying and selling .three for each cent lower at forty one,456 ranges.